Physician
Radiation Oncology
Dr. Daniel L. Glaubiger, MD
|
|
Give Review
Dr. Daniel L. Glaubiger is an expert in the field of Radiation Oncology. He went to medical school at University of California San Francisco School of Medicine. University of California San Francisco School of Medicine is one of the top medical schools in the US. University of California San Francisco School of Medicine is ranked 3/3 in Research/PrimaryCare. Doctor Daniel L. Glaubiger, MD is also published. He has 60 publications published. The lastest publication: "Intensive combined modality therapy including low-dose TBI in high-risk Ewing's Sarcoma Patients.'
Publications
- Intensive combined modality therapy including low-dose TBI in high-risk Ewing's Sarcoma Patients.
- Effects of 8-methoxypsoralen and ultraviolet radiation on human lymphoid cells in vitro.
- Local control of Ewing's sarcoma of bone with radiotherapy and combination chemotherapy.
- Active transport of methotrexate from cerebrospinal fluid in humans.
- Determination of prognostic factors and their influence on therapeutic results in patients with Ewing's sarcoma.
- Influence of prognostic factors on survival in Ewing's sarcoma.
- Tolerance to single-dose dactinomycin in combination chemotherapy for solid tumors.
- Leg function after radiotherapy for Ewing's sarcoma.
- Initial experience with the human tumor stem cell assay system: potential and problems.
- DNA crosslinking and cell survival in human lymphoid cells treated with 8-methoxypsoralen and long wavelength ultraviolet radiation.
- The radiographic follow-up of patients with Ewing sarcoma: a demonstration of a general method.
- Assessment of in vitro drug sensitivity of human tumor cells using [3H]thymidine incorporation in a modified human tumor stem cell assay.
- The frequency of isolated CNS involvement in Ewing's sarcoma.
- Pharmacokinetics of leucovorin rescue using a new methotrexate-independent biochemical assay for leucovorin and N5-methyltetrahydrofolate.
- Interstrand DNA crosslinking by 4,5''8-trimethylpsoralen plus monochromatic ultraviolet light. Studies by alkaline elution in mouse L1210 leukemia cells.
- Phase I study of 2'-deoxycoformycin in acute lymphoblastic leukemia.
- Influence of tetrahydrouridine on the pharmacokinetics of intrathecally administered 1-beta-D-arabinofuranosylcytosine.
- L-asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of rhesus monkeys and humans.
- Correlation of cellular tritiated thymidine incorporation with soft agar clonogenicity in chemosensitivity testing of human neuroblastoma cells.
- Controlled clinical trials of nutritional intervention as an adjunct to chemotherapy, with a comment on nutrition and drug resistance.
- Differences in lipid composition of doxorubicin-sensitive and -resistant P388 cells.
- Probenecid inhibition of methotrexate cytotoxicity in mouse L1210 leukemia cells.
- Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by perhexiline maleate.
- Extraskeletal Ewing's sarcoma: results of combined modality treatment.
- Birth defects with Ewing's sarcoma.
- Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by tamoxifen and other triparanol analogues.
- The relative tolerance of children and adults to anticancer drugs.
- Electrolytic degradation of DNA fluorochromes during flow cytometric measurement of electronic cell volume.
- Enhancement of doxorubicin and vinblastine sensitivity in anthracycline-resistant P388 cells.
- Oxygen radical detoxification enzymes in doxorubicin-sensitive and -resistant P388 murine leukemia cells.
- 5''-Nucleotidase activity and arachidonate metabolism in doxorubicin sensitive and resistant P388 cells.
- Plasma membrane lipid structural order in doxorubicin-sensitive and -resistant P388 cells.
- Phase II study of 5-azacytidine in sarcomas of bone.
- Result of attempted hematopoietic reconstitution using isologous, peripheral blood mononuclear cells: a case report.
- Haemopoietic recovery in Ewing''s sarcoma after intensive combination therapy and autologous marrow infusion.
- Effect of superhelical structure on the secondary structure of DNA rings.
- Temperature-dependent optical properties of a torsional oscillator model for dinucleoside phosphates.
- The reaction of anthramycin with DNA. 3. Properties of the complex.
- The reaction of anthramycin with DNA. II. Studies of kinetics and mechanism.
- Very high dose cyclophosphamide with imidazole carboximide and vincristine sulfate in the treatment of stage IV neuroblastoma.
- Phase I trial of mitoxantrone in children.
- Actuarial risk of isolated CNS involvement in Ewing's sarcoma following prophylactic cranial irradiation and intrathecal methotrexate.
- Diagnosis of pulmonary nodules in the cancer patient: the role for routine culture and an unusual application of the human tumor colony-forming assay.
- Conservative treatment of breast cancer in Europe: report of the Groupe Européen de Curiethérapie.
- Salvage irradiation of oropharyngeal cancers using iridium 192 wire implants: 5-year results of 70 cases.
- Phase I study of ICRF-187 in pediatric cancer patients and comparison of its pharmacokinetics in children and adults.
- Treatment of sarcomas of the chest wall using intensive combined modality therapy.
- Chondrosarcoma of the larynx after radiation treatment for vocal cord cancer.
- Intercalative binding of ellipticine to DNA.
- Combined modality treatment of Burkitt''s lymphoma.
- Probenecid inhibition of methotrexate excretion from cerebrospinal fluid in dogs.
- Probenecid inhibition of methotrexate-cerebrospinal fluid pharmacokinetics in dogs.
- Structural limitations on the bifunctional intercalation of diacridines into DNA.
- Protein-associated DNA breaks in cells treated with adriamycin or ellipticine.
- Qualitative and quantitative aspects of intercalator-induced DNA strand breaks.
- Azaserine, DON, and azotomycin: three diazo analogs of L-glutamine with clinical antitumor activity.
- Duration of empiric antibiotic therapy in granulocytopenic patients with cancer.
- Phase I study of methanesulfonamide, N-[4-(9-acridinylamino)-3-methoxyphenyl]-(m-AMSA) using a single-dose schedule.
- Subsequent cancer in patients with Ewing''s sarcoma.
Schools
University Of California San Francisco School Of Medicine
Stanford University Medical Center
National Cancer Institute amp Uniformed Services University Of The Health Sciences
National Cancer Institute
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Education
-
National Institutes of Health Clinical Center -
Stanford University -
University of California San Francisco School of Medicine
Helpful Reviews
Similar Doctors
|
Dr. John L. Meyer, MD |
|
|
Dr. Gautam Prasad, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daphne A. Haas-Kogan, MD
This Doctor is OpenDoctor Recommended.
|